Search

Promoting growth

Long-term partner for start-ups

We have already accompanied over 100 start-up projects. We usually acquire a minority share in the resulting companies.

We continue to support our portfolio companies on their growth trajectory and manage our shares as profitably as possible until exit – or, in the case of floatation or takeovers by listed companies, beyond.

We distribute most of our revenues from the sale of equity and shares to the LifeScience Foundation, which in turn makes them available to its endowing institutes as research grants

Current shareholdings

Klaria

Development of new therapeutics with the Alginate Film Transmucosal Delivery technology for diseases with high unmet medical needs

Former shareholdings

    • Activaero GmbH

    • Bioregeneration GmbH

    • BITZ GmbH

    • Clueda AG

    • eADMET GmbH

    • Encepharm GmbH

    • Genomatix GmbH

    • Inamed GmbH

    • SurgVision B.V.

    • Trianta Immunotherapies GmbH

    • TRION Pharma GmbH

    • Vakzine Projekt Management GmbH

    • WBC Drug Delivery Technologies

    • Zellkraftwerk GmbH

    • Activaero GmbH

    • Alerion

    • amcure GmbH

    • BigChem GmbH

    • Biomax AG

    • Bioregeneration GmbH

    • BITZ GmbH

    • Canopy Biosciences

    • Consentris GmbH

    • Clueda AG

    • CoImmune

    • DentalXrai

    • eADMET GmbH

    • Encepharm GmbH

    • Genomatix GmbH

    • Inamed GmbH

    • NanoRepro AG

    • Spero Therapeutics LLC

    • SurgVision B.V.

    • Trianta Immunotherapies GmbH

    • TRION Pharma GmbH

    • Tube Pharmaceutical GmbH

    • Vakzine Projekt Management GmbH

    • Vectura Group plc

    • WBC Drug Delivery Technologies

    • Zellkraftwerk GmbH

    • amcure GmbH

    • DentalXrai

    • Vectura Group plc

    • Consentris GmbH

    • Tube Pharmaceutical GmbH

    • WBC Drug Delivery Technologies

    • CoImmune